1. Genes transcriptionally modulated by interferon alpha2a correlate with the cytokine activity.
- Author
-
Iolascon A, Volinia S, Borriello A, Giordani L, Moretti A, Servedio V, Maiorano N, Cucciolla V, Criniti V, Gasparini P, Indaco S, and Della Ragione F
- Subjects
- Apoptosis Regulatory Proteins biosynthesis, Apoptosis Regulatory Proteins genetics, Base Sequence, Carcinoma, Hepatocellular pathology, Cell Line, Tumor drug effects, Cell Line, Tumor metabolism, Cycloheximide pharmacology, Cytokines biosynthesis, Humans, Interferon alpha-2, Interferon-Stimulated Gene Factor 3, gamma Subunit biosynthesis, Interferon-Stimulated Gene Factor 3, gamma Subunit genetics, K562 Cells drug effects, K562 Cells metabolism, Liver Neoplasms pathology, Membrane Transport Proteins biosynthesis, Membrane Transport Proteins genetics, Molecular Sequence Data, Myelin Proteins biosynthesis, Myelin Proteins genetics, Myelin and Lymphocyte-Associated Proteolipid Proteins, Neoplasm Proteins biosynthesis, Oligonucleotide Array Sequence Analysis, Promoter Regions, Genetic, Protein Synthesis Inhibitors pharmacology, Proteolipids biosynthesis, Proteolipids genetics, Recombinant Proteins, Rhabdomyosarcoma pathology, Ribonucleoproteins biosynthesis, Ribonucleoproteins genetics, STAT1 Transcription Factor biosynthesis, STAT1 Transcription Factor genetics, STAT2 Transcription Factor biosynthesis, STAT2 Transcription Factor genetics, Cytokines genetics, Gene Expression Regulation, Neoplastic drug effects, Interferon-alpha pharmacology, Neoplasm Proteins genetics, Transcription, Genetic drug effects
- Abstract
Background and Objectives: Interferon alpha2a (IFNalpha2a) mediates important antiviral, antiproliferative and immunomodulatory responses and is employed in the treatment of human diseases, including chronic myelogenous leukemia. Here, we report the IFNalpha2a-dependent expression profiles of three malignant cell lines derived from liver, lymphocytes and muscle., Design and Methods: The experiments were performed in the presence of cycloheximide, thus our results exclusively reflect direct transcriptional modulation. The short exposure time i.e. 5 hours evidences only the early events, excluding the effects of complex phenotypic changes on the expression., Results: Our findings indicate that IFNalpha2a rapidly up-regulates the expression of STAT1, STAT2 and ISGF3G genes. This activity should result in the amplification of the cellular response to the cytokine. Moreover, IFNalpha2a directly modulates the expression of: (i) important transcriptional factors, e.g. IRF1 and IRF7 which control pivotal cellular events, and (ii) enzymes involved in the IFNalpha2a-dependent antiviral and apoptotic response. Interestingly, we showed that the cytokine induces transcriptional expression of Sjögren's syndrome antigen A1, a protein involved in several autoimmune diseases., Interpretation and Conclusions: The observed changes induced by IFNalpha2a could be related to the development of autoimmune syndromes observed during IFNalpha2a treatment. A number of genes transcriptionally regulated by the cytokine have been identified for the first time; these might represent additional effectors of IFNalpha2a activity.
- Published
- 2004